1. Home
  2. VKTX vs GEO Comparison

VKTX vs GEO Comparison

Compare VKTX & GEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • GEO
  • Stock Information
  • Founded
  • VKTX 2012
  • GEO 1984
  • Country
  • VKTX United States
  • GEO United States
  • Employees
  • VKTX N/A
  • GEO N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • GEO Homebuilding
  • Sector
  • VKTX Health Care
  • GEO Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • GEO Nasdaq
  • Market Cap
  • VKTX 3.5B
  • GEO 3.7B
  • IPO Year
  • VKTX 2015
  • GEO 1994
  • Fundamental
  • Price
  • VKTX $40.03
  • GEO $21.03
  • Analyst Decision
  • VKTX Strong Buy
  • GEO Strong Buy
  • Analyst Count
  • VKTX 13
  • GEO 5
  • Target Price
  • VKTX $86.92
  • GEO $42.00
  • AVG Volume (30 Days)
  • VKTX 4.6M
  • GEO 3.8M
  • Earning Date
  • VKTX 07-23-2025
  • GEO 08-06-2025
  • Dividend Yield
  • VKTX N/A
  • GEO N/A
  • EPS Growth
  • VKTX N/A
  • GEO 153.61
  • EPS
  • VKTX N/A
  • GEO 0.63
  • Revenue
  • VKTX N/A
  • GEO $2,452,358,000.00
  • Revenue This Year
  • VKTX N/A
  • GEO $8.22
  • Revenue Next Year
  • VKTX $338.60
  • GEO $25.89
  • P/E Ratio
  • VKTX N/A
  • GEO $33.51
  • Revenue Growth
  • VKTX N/A
  • GEO 1.17
  • 52 Week Low
  • VKTX $18.92
  • GEO $11.75
  • 52 Week High
  • VKTX $81.73
  • GEO $36.46
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 69.97
  • GEO 35.24
  • Support Level
  • VKTX $39.35
  • GEO $19.79
  • Resistance Level
  • VKTX $41.68
  • GEO $27.09
  • Average True Range (ATR)
  • VKTX 2.06
  • GEO 1.31
  • MACD
  • VKTX 0.56
  • GEO -0.37
  • Stochastic Oscillator
  • VKTX 84.10
  • GEO 16.99

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About GEO Geo Group Inc (The) REIT

The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.

Share on Social Networks: